Next Article in Journal
Impact of the COVID-19 Italian Lockdown on the Physiological and Psychological Well-Being of Children with Fragile X Syndrome and Their Families
Next Article in Special Issue
The Effect of Bilateral Nephrectomy on Renalase and Catecholamines in Hemodialysis Patients
Previous Article in Journal
Sustainable Wheat Production and Food Security of Domestic Wheat in Tajikistan: Implications of Seed Health and Protein Quality
Previous Article in Special Issue
Insulin Withdrawal in Diabetic Kidney Disease: What Are We Waiting for?
Editorial

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

1
Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain
2
School of Medicine, Universidad de Valencia, 46010 Valencia, Spain
3
Digestive Medicine Department, Hospital Clínico Universitario de Valencia, 46010 València, Spain
4
Nephrology Department, Hospital Dr. Peset, FISABIO, 46017 València, Spain
5
Nephrology Department, Hospital de Castellón, 12004 Castellón, Spain
*
Authors to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(11), 5748; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115748
Received: 2 May 2021 / Accepted: 25 May 2021 / Published: 27 May 2021
(This article belongs to the Special Issue Chronic Kidney Disease: The Global Challenge)
Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with vaccination in the case of HBV and effective viral infection treatment for HCV. In this sense, a universal SARS-CoV-2 screening and contact precaution appear to be effective in preventing further transmission. Finally, regarding the progress, an international consensus with updated protocols that prioritize between old and new indicators would seem a reasonable tool to address these unexpended changes for the nephrology community. View Full-Text
Keywords: chronic kidney disease; hepatitis; SARS-CoV-2; COVID19; dialysis chronic kidney disease; hepatitis; SARS-CoV-2; COVID19; dialysis
Show Figures

Figure 1

MDPI and ACS Style

D’Marco, L.; Puchades, M.J.; Serra, M.Á.; Gandía, L.; Romero-Alcaide, S.; Giménez-Civera, E.; Molina, P.; Panizo, N.; Reque, J.; Gorriz, J.L. SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect? Int. J. Environ. Res. Public Health 2021, 18, 5748. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115748

AMA Style

D’Marco L, Puchades MJ, Serra MÁ, Gandía L, Romero-Alcaide S, Giménez-Civera E, Molina P, Panizo N, Reque J, Gorriz JL. SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect? International Journal of Environmental Research and Public Health. 2021; 18(11):5748. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115748

Chicago/Turabian Style

D’Marco, Luis, María J. Puchades, Miguel Á. Serra, Lorena Gandía, Sergio Romero-Alcaide, Elena Giménez-Civera, Pablo Molina, Nayara Panizo, Javier Reque, and José L. Gorriz 2021. "SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?" International Journal of Environmental Research and Public Health 18, no. 11: 5748. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115748

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop